Procurement Summary
Country : USA
Summary : Reagents and Controls with Use of Sysmex xn-3000 Hematology Automation System W/ Cellavision
Deadline : 08 Oct 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 71415811
Document Ref. No. : W81K0222F0142
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Posting of Sole Source Justification and Approval under FAR 8.405-6(a)(1)(i)(B)
Items being purchased are reagents and controls to be used with the Sysmex xN-3000 Hematology Automation System with CellaVision for the Department of Pathology, Hematology Laboratory at the Tripler Army Medical Center. Period of performance is 1 October 2022 through 30 September 2023 (base) plus one one-year option.
Active Contract Opportunity
Notice ID : W81K0222F0142
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEPT OF THE ARMY
Major Command : MEDCOM
Office : W40M RHCO PACIFIC
General Information
Contract Opportunity Type: Justification (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Sep 07, 2022 08:59 pm EDT
Inactive Policy: 30 days after published date
Original Inactive Date: Oct 08, 2022
Authority: Only One Source (except brand name)
Initiative: None
Classification
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
Place of Performance: USA
Documents
Tender Notice
JA_Sysmex-America_Redacted.pdf